Literature DB >> 17639754

Interaction between warfarin and levofloxacin: case series.

Raja S Vadlamudi1, Roger D Smalligan, Hassan M Ismail.   

Abstract

Warfarin is the most widely used oral anticoagulant and is indicated for many clinical conditions. Levofloxacin, a fluoroquinolone, is one of the most commonly prescribed antibiotics in clinical practice and is effective against Gram-positive, Gram-negative, and atypical bacteria. While small prospective studies have not revealed any significant drug-drug interaction between warfarin and levofloxacin, several case reports have indicated that levofloxacin may significantly potentiate the anticoagulation effect of warfarin. We report 3 cases of serious bleeding complications that appear to be the result of the interaction between warfarin and levofloxacin. Physicians should be aware of this potential interaction and use caution when prescribing levofloxacin to patients taking warfarin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639754     DOI: 10.1097/SMJ.0b013e318073c7ee

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.

Authors:  Edith Nutescu; Ittiporn Chuatrisorn; Erika Hellenbart
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

2.  Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German database.

Authors:  Kathrin Jobski; Sigrid Behr; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2011-03-31       Impact factor: 2.953

3.  Retrospective assessment of potential interaction between levofloxacin and warfarin.

Authors:  Gabriel Mercadal Orfila; Berta Gracia García; Elisabet Leiva Badosa; María Perayre Badía; Concepción Reynaldo Martínez; Ramón Jodar Masanés
Journal:  Pharm World Sci       Date:  2008-12-06

Review 4.  Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns.

Authors:  Chu-Han Gao; Lu-Shan Yu; Su Zeng; Yu-Wen Huang; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2014-03-27       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.